insights_auto
Outlook: 70.6% bullish·0.0% bearish
Go to analysischevron_right
REGN:NASDAQ
Regeneron Pharmaceuticals Inc
$746.54
arrow_upward
+0.94%(+6.97) 1D
Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
$737.20
High
$751.27
Low
$732.83
Mkt. cap
76.86B
Avg. vol.
720.68K
Volume
20.00
Dividend
0.50%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
18.46
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.16
Shares outstanding
101.14M
No. of employees
15K
Open
$737.20
High
$751.27
Low
$732.83
Mkt. cap
76.86B
Avg. vol.
720.68K
Volume
20.00
Dividend
0.50%
Quarterly dividend
$0.94
Ex-dividend date
Aug 18, 2026
P/E ratio
18.46
52-wk high
$859.34
52-wk low
$541.00
EPS
$40.45
Beta
0.16
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
Simply Wall Street
·
9 hours ago
Should Alliance Expansion Require Action From Regeneron (REGN) Investors?
AD HOC NEWS
·
2 days ago
Regeneron stock costs EUR 668.30 with USD 77.1 billion market cap
AD HOC NEWS
·
3 days ago
Regeneron stock pre-market: EUR 659.95, plus 0.05 percent
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com